Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suramin (PAX-101) in Male Children with ASD
NCT06058962Phase 2Completed
- Sponsor
- PaxMedica, Inc.
- Start
- Jun 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suramin in Autism Spectrum Disorder (ASD), sponsored by PaxMedica, Inc.. Started Jun 2019; status: completed.
02
Drugs
suramin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT06058962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06058962.